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ABSTRACT 
   Metabolic syndrome, a clustering of components that reflect overnutrition, sedentary lifestyles, and 
excess adiposity, has become a major health problem worldwide. The increase in its prevalence could be 
the result of the increase in obesity and insulin resistance. It is suggested that modification of lifestyle 
including increasing exercise and improving dietary habits is an effective approach for management of 
the metabolic syndrome. No single diet is recommended for patients with metabolic syndrome. This 
paper will review the data and make an evidence-based recommendation for the optimal dietary patterns 
for reducing cardiometabolic risk. 
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INTRODUCTION 
   Metabolic Syndrome (MetS), also known as 
“insulin resistance syndrome” [1], “deadly 
quartet” [2] or “syndrome X” [3], is a clustering 
of components that reflect obesity, physical 
inactivity and consumption of an atherogenic 
and diabetogenic diet [4]. Individual 
components that define metabolic syndrome 
include dysglycemia, raised blood pressure, 
elevated triglyceride (TG) levels, low high-
density lipoprotein cholesterol (HDL-C) levels, 
obesity, particularly central obesity [4, 5] and 
recently, a pro-inflammatory and prothrombic 
state [6, 7]. The number of studies on MetS in 
the last two decades indicates the scientific and 
clinical importance of MetS. The MetS has 
made its place in the medical literature with 
more than 32,000 citations now recorded in 
PubMed. Most studies show 2 fold increase in 
risk of cardiovascular disease (CVD) and 5 fold 
increase in risk of type 2 diabetes (T2D) in 
people with MetS [8, 9]. Recent studies have 
shown the association of MetS with cancer [10, 
11] and chronic kidney disease [12] as well as 
all cause mortality [13, 14]. Although there is 
no consensus on the etiology of MetS, it is 
generally accepted that the prevalence of this 
syndrome is increasing throughout the world in 
parallel with the increase in obesity [15] so 
prevention of this syndrome is necessary to 
reduce the associated mortality and morbidity 
costs[16]. 
Increasing physical activity and reducing weight 
is essential for prevention and treatment of 
MetS but there is no consensus on a single 
appropriate diet for people with Mets. Thus the 
aim of this work was to review the current 
nutritional recommendations for prevention and 
treatment of MetS.  In order to fulfillment of 
our aim, we reviewed the information from 
epidemiological and interventional studies on 
dietary and lifestyle practices proposed for 
management of MetS. Studies which were 
published until January 30, 2013 were selected 
through a computer assisted published data 
search on PubMed, Scopus, Sciencedirect, 
Wiley, Springer and Google Scholar databases 
using  keywords related to the aim of the study 
(i.e., Metabolic syndrome, Syndrome X, Diet, 
Nutrition, Dietary Pattern, Treatment, 
Prevention, Lifestyle).   
 
CLINICAL MANAGEMENT OF METS 
According to a report from the National 
Cholesterol Education Program’s Adult 
Treatment Panel III (NCEP: ATPIII) the 
primary goal of management of MetS is to 
reduce the risk CVD and T2D. Overall goals of 
reducing the risk for or preventing CVD and 
T2D according to MetS components are 
summarized in table 1 [17]. 
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Table 1. Overall goals of reducing the risk for or preventing CVD and T2D according to MetS components 
Adapted from (17) 
 
Since the first description of MetS by kylin in 
1920 [18], different strategies including 
lifestyle modification, drug therapy and 
weight loss surgery have been implied to 
reduced the risk of the whole syndrome or its 
individual components. In a recent review, 
Giugliano [19] has showed that the most 
effective approach to reduce the risk of  MetS 
is weight loss surgery with a 93% reduction in 
the risk of MetS in compare with the effect of 
lifestyle modification (25%) and drug therapy 
(19%) on reducing the risk of the syndrome. 
Despite its striking effectiveness, weight 
reduction surgery can not be a routine 
treatment of the MetS because many of the 
people with MetS are not a candidate for 
weight loss surgery [20].  
Lifestyle modifications including weight loss, 
increased physical activity and dietary 
modifications have been demonstrated to 
improve all of the components of MetS 
simultaneously [21-24]. Among the drugs 
used to treat MetS, only the weight reduction 
drugs (i.e. sibutramine and orlistat) may have 
the same effect. However many adverse side 
effects of these drugs have limited their use in 
many patients [25].  
Other drugs that are used to correct individual 
components of MetS do not improve all of 
them simultaneously [26]. 
 For these reasons lifestyle modifications are 
considered to have priority over drug 
treatment and ATP III has proposed lifestyle 
modifications as the first line intervention in 
clinical management of MetS [6].  
 
LIFESTYLE MODIFICATION 
   Therapeutic lifestyle changes have been 
demonstrated to improve individual components 
of MetS as well as the whole syndrome. In a 
meta-analysis Yamaoka et al. [27] found that 
lifestyle and dietary education can effectively 
reduce 2-hour plasma glucose level and the 
incidence rate of T2D in patients at high risk of 
T2D. Data from another meta-analysis placed 
emphasis on the evidence that long-term regular 
lifestyle modification, including achieving and 
maintaining a weight reduction through diet and 
moderate-intensity physical activity is two times 
more effective at resolving the MetS in compare 
to control group [21]. It is proposed that the 
initial therapeutic approach to MetS through 
lifestyle modification is reversing its key roots 
including a sedentary lifestyle, overweight or 
obesity and an atherogenic/diabetogenic diet 
[19]. 
Physical Activity  
   Increasing physical activity can moderate 
CVD risk [28], incidence of T2D [29] and 
protects against development of MetS through 
its effects on the whole syndrome as well as 
each of the individual components [29-32]. 
Physical activity is particularly effective at 
reducing insulin resistance [33, 34] and 
hypertension [35] and also improving 
dyslipidemia, especially increasing HDL-C 
level [35-37]. Meanwhile regular exercise 
prevents weight regain in those who have lost 
weight [38, 39] and play an important role in 
abdominal fat loss [33, 40]. Both aerobic and 
resistance exercise seems to be beneficial for 
patients with MetS. Aerobic exercise is the 
Treatment Targets  Goals and Recommendations  
Abdominal obesity  5–10% Weight loss or weight maintenance 
Lifestyle modification with diet and  increased physical activity 
   Pharmacological weight loss therapy 
   Bariatric surgery 
Insulin resistance/hyperglycemia Prevention or delay of progression to type 2 diabetes 
   Lifestyle modification and weight loss as described above 
   Pharmacotherapy 
Treatment of diabetes 
   Appropriate glycemic control 
Metabolic dyslipidemia 
   Primary target: LDL-C  
   Secondary target: non-HDL-C  
   Tertiary target: HDL-C  
LDL-C lowering as per NCEP:ATPIII goals 
If TG _200 mg/dl, lower non-HDL-C to 30 mg/dl plus the LDL-C goal 
If HDL-C <40 mg/dl in men or <50 mg/dl in women, consider  
therapy for HDL-C raising 
Elevated blood pressure   Goal BP is <140/90 mm Hg (<130/80 mm Hg if diabetes  
or CKD present) 
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cornerstone of preventing Mets because it 
improves insulin resistance. Resistance exercise 
also provide additional benefit because it 
increases the muscle mass, promotes a negative 
energy balance and leads to weight loss and 
better metabolic control [41, 42]. The 2008 
physical activity guidelines suggest that all 
individuals have at least 150 minutes per week 
of moderate-intensity physical activity. All 
individuals should also have at least 2 days per 
week of resistance exercise activity. If weight 
loss is the goal, the combination of physical 
activity and reduced energy intake has been 
demonstrated to be more effective than either 
alone [42].  
Weight Loss 
   Weight loss has profound role in treating all 
of the components of MetS, including obesity, 
dyslipidemia, hypertension, insulin resistance, 
and hyperglycemia [43, 44]. Even modest 
weight loss can significantly reduce the 
prevalence of MetS [44]. It is shown that 5–
10% reduction of body weight significantly 
reduces triglycerides and increase HDL-C [45]. 
Weight loss predicts the reduction in the 
incidence of diabetes and for every kilogram of 
weight loss the risk of diabetes development 
decreases by 16% [46].  
In a recent review, Leão et al has shown that 
low-calorie diets combined with physical 
activity is the most effective strategy to improve 
MetS [47]. Low-calorie diet can specifically 
improve insulin resistance and obesity which 
are at the core of the pathophysiology of this 
syndrome.  
Healthy Diet  
   In either a normo-calorie or a low-calorie diet 
the composition of the whole diet and 
distribution of macronutrients consumed are 
also important because they influence the 
individual components of MetS as well as the 
overall health of the patient. The first dietary 
recommendations proposed by ATP III and 
American Heart Association (AHA) include 
moderate fat intake (25%-35% of energy), low 
saturated fat intake (<7% of total energy), 
avoidance of trans fat, limited cholesterol 
(<300mg/d) and refined sugar, high intakes of 
fruits, vegetables and whole grains [5, 48]. 
These recommendations traditionally emphasize 
on lowering LDL-C level to reduce the risk of 
CVD. In management of MetS, triglyceride and 
HDL-C level are also important, so more 
detailed recommendation are required [49].  
Macronutrient Distribution of Diet 
   Recommendations for resolving MetS 
traditionally focused on lowering fat intake. 
Although low fat diets effectively reduce LDL-
C, they have adverse effect on TG and HDL-C 
[50, 51] and insulin resistance [52]. Low fat 
intake may lead to high intake of refined 
carbohydrates [53, 54]. High carbohydrate 
intake, especially refined carbohydrates is 
associated with high blood pressure [55]. Data 
from NHANES III also shows high intake of 
carbohydrate (>60% energy intake) in men is 
associated with MetS [56].  
Low carbohydrate diets may be more effective 
at resolving MetS than low fat diets [57-60]. In 
low carbohydrate diets, <30% of total energy 
intake is from carbohydrate [61] or total daily 
intake of carbohydrate is in the range of 50-150 
grams [62]. Low carbohydrate diet is associated 
with lower TG concentration and higher HDL 
concentration [63, 64] as well as rapid weight 
loss and insulin level reduction over short 
periods of time [65]. However, in such diets 
uncontrolled intake of high fat meats and 
products may induce adverse metabolic effects 
for patients with MetS [66].  
Diets high in protein have also been proposed 
for the treatment of MetS [67]. In addition to 
rapid weight loss, these diets improve body 
composition. It has been demonstrated that 
increasing dietary protein content (30%) and 
decreasing carbohydrates (40%) reduce fat 
mass, especially abdominal fat mass [68].  
Positive effects of high-protein low- CHO diets 
on reducing risk factors for MetS have been 
reported. These effects include reducing serum 
TG, increasing HDL cholesterol, increasing 
LDL particle size, and reducing blood pressure 
[69-71]. Studies show that replacing dietary 
carbohydrate with either fat or protein reduce 
triacylglycerides and increase HDL cholesterol 
even under weight-stable conditions [72, 73]. 
However, substitution with protein may be more 
effective for improving lipid prolife [72-74] and 
insulin action [73, 75]. Finally, scientific 
evidence suggests that reducing dietary 
carbohydrate is the primary means of 
prevention or treatment of MetS. Increasing 
dietary protein as an approach to lowering 
dietary carbohydrates may be more effective 
than increasing fat [65, 76, 77]. 
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   With increasing evidence on complexity of 
diets consumed by free-living individuals, it is 
suggested that studying dietary pattern or all 
components of diet as a single exposure would 
be a powerful approach to describe the 
association between diet and chronic diseases 
including MetS [78, 79]. Williams et al. in a 
cross sectional study demonstrated that a 
healthy balanced diet high in raw and salad 
vegetables, fruits, fish, pasta, and rice and low 
in fried foods, sausages, fried fish, and potatoes 
was negatively associated with central obesity, 
fasting plasma glucose, and triacylglycerols and 
also positively associated with HDL-C [80]. 
Since then several epidemiological studies have 
demonstrated that diets rich in fruit, vegetables, 
whole grains, low fat dairy products and 
monounsaturated and polyunsaturated fats are 
associated with a lower prevalence of the 
metabolic syndrome while high intake of 
processed meat, fried foods, sugar-sweetened 
beverages, refined carbohydrates and processed 
cereals with high glycemic index are associated 
with high prevalence of Mets in men and 
women [81-88].  
One of the main outcomes of the initial 
epidemiological evidence was guidelines 
proposed by ATP III and AHA known as 
Therapeutic Lifestyle Change diet (TLC) 
guidelines. Nutrient composition of TLC Diet is 
summarized in table 2. The efficacy of these 
recommendations has been evaluated in clinical 
trial studies. It has been shown that following 
these guidelines in combination with exercise 
significantly reduces body weight and waist 
circumference in women with MetS after 6 
month [89]. In another study, 4-month lifestyle 
modification education based on TLC in Iranian 
adults using mentioned guidelines improved 
total cholesterol and LDL-C significantly in 
Iranian adults with MetS [90]. 
 
 
Table 2. Nutrient Composition of the TLC Diet  
Nutrients Recommended Intake 
Saturated fat  < 7% of total calories  
Trans fat < 1% of total calories 
Polyunsaturated fat  Up to 10% of total calories  
Monounsaturated fat  Up to 20% of total calories  
Total fat  25% to 35% of total calories  
Carbohydrate  50% to 60% of total calories  
Fiber  20-30 g/day  
Protein  Approximately 15% of total calories  
Cholesterol  < 200 mg/day  
Total calories  Balance energy intake and expenditure to maintain desirable body 
weight/prevent weight gain  Adapted from (4) 
 
The Dietary Approaches to Stop Hypertension 
or DASH diet is another dietary approach 
proposed for management of MetS. DASH 
Dietary pattern emphasizes on high intake of 
fruits, vegetables, low-fat dairy foods, whole 
grains, poultry, fish, and nuts, seeds and 
legumes. Additionally, it is low in saturated fat, 
total fat, cholesterol, red meat, sweets, sugared 
beverages and refined grains. Calcium, 
potassium and fiber intake in this dietary pattern 
is high but the amount of sodium intake is low 
(i.e., 2,400 mg per day) [91, 92].While DASH 
was originally developed to manage or prevent 
high blood pressure [93], it has been found to 
have many additional advantages and is now 
recommended for all adults [91]. Azadbakht et 
al. in a clinical trial on 116 men and women 
with MetS demonstrated that 6-month 
intervention with DASH diet significantly 
reduced body weight, waist circumference, TG, 
systolic blood pressure, diastolic blood pressure, 
and fasting blood sugar and also increased 
HDL-C [94], thus reduced the risk of the 
syndrome by 20%. In a randomized crossover 
clinical trial beneficial effects of DASH diet to 
reduce cardiometabolic risks among type 2 
diabetic patients was also shown [95]. However, 
a recent review article emphasized the fact that 
significant improvements in insulin sensitivity 
are observed only when the DASH diet is 
implemented as part of a more comprehensive 
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lifestyle modification program that includes 
exercise and weight loss [96]. 
The Mediterranean diet (MD) which was first 
introduced by Ancel Keys in 1960s [97], is not 
a specific diet, but rather a collection of eating 
habits traditionally followed by people in the 
different countries bordering the Mediterranean 
Sea including Greece, Spain, southern Italy, 
Portugal, and Turkey. This dietary pattern is 
characterized by daily consumption of 
nonrefined cereals, vegetables (two or three 
servings per day), fruit (four to six servings per 
day), different olive oil products and nonfat or 
low-fat dairy products (one or two servings per 
day); weekly consumption of potatoes (four to 
five servings per week), fish (four to five 
servings per week),olives, pulses and nuts 
(more than four servings per week), and more 
rarely poultry, eggs, and sweets (one to three 
servings per week), and monthly consumption 
of red meat and meat products(four or five 
servings per month) as well as a moderate daily 
consumption of alcohol, normally with meals 
[98, 99]. MD has been shown to be the optimal 
diet for preventing non communicable diseases 
and preserving good health [99, 100]. While 
MD is a well known cardioprotective diet [101-
103] its beneficial roles with regard to all cause 
mortality and cancer as well as obesity and 
TDM have also been shown in epidemiological 
studies and clinical trials [100, 104-111]. The 
MD also protects against MetS and its 
individual components and is more effective in 
resolution of the syndrome compared to the 
DASH diet [47].  
Esposito et al. in a randomized clinical trial on 
180 men and women demonstrated that over a 
course of 24 month intervention with MD, 
prevalence of MetS reduced by approximately 
50%. The reduction in the prevalence of MetS 
was owed to significant decreases in waist 
circumference, blood pressure, plasma glucose, 
total cholesterol, and triglyceride 
concentrations, and a significant increase in 
HDL in the intervention group [112].  
A recent systematic review and meta-analysis of 
50 studies including both observational studies 
and randomized controlled trials reinforced the 
benefits of  MD on improving the MetS and its 
individual components and revealed that 
adherence with MD reduced the risk of 
developing this syndrome by 31% [113]. 
Antioxidant and anti-inflammatory properties of 
the foods included in MD as well as high intake 
of vitamins and minerals guarantee the 
protection against MetS. Recently it is shown 
that 2 month intervention with MD effectively 
increases total dietary antioxidant intake and 
plasma total antioxidant capacity [114].  
Olive oil is one of main food items of MD 
which has been shown to improve 
cardiovascular risk factors, such as lipid 
profiles, blood pressure, postprandial 
hyperlipidemia, endothelial dysfunction, 
oxidative stress, and antithrombotic profiles 
[115, 116]. Phenolic compounds in olive oil 
have also shown antioxidant and anti-
inflammatory properties that improve 
endothelial function [117, 118].  
Meanwhile olive oil lowers NF-kB activation, 
thus leads to decrease in markers of 
inflammation (CRP, IL-6, IL-8), oxidation, and 
thrombosis  [119]. Nuts are another high-
unsaturated fat food commonly consumed in the 
MD. Epidemiological and clinical trial studies 
suggests that regular nuts intake might have a 
positive impact on adiposity [120, 121], insulin 
resistance [120] and other metabolic 
disturbances linked to the MetS and CVD [122].  
 
CONCLUSION 
   Regarding the increase in the incidence of 
MetS serious action should be taken to control 
the whole syndrome and its individual 
components.  
As shown in this review, the most applicable 
strategy to prevent and treat MetS is improving 
lifestyle through keeping healthy weight, 
following a healthy diet and increasing physical 
activity. Although the ideal diet should be 
personalized to each patient, dietary factors 
which are beneficial for effective weight loss 
and weight maintenance as well as for reducing 
cardiovascular and diabetes risk should be 
recommended for all.  
Summary of research suggest that high intake of 
foods rich in antioxidants including fruit and 
vegetables as well as foods rich in 
monounsaturated fat such as olive and olive oil, 
a balanced intake of carbohydrates rich in 
dietary fiber and low intake of saturated and 
trans fat, in combination with regular exercise 
may be beneficial for management of MetS and 
its components. Further randomized clinical 
trials are needed in order to establish if it is the 
best option for the patients with MetS. 
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